|
Novel Stimulation to Improve Respiratory Function in ARDS and Severe COVID-19 Patients |
1R43HL162180-01A1 |
|
NHLBI |
2022 |
|
DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME |
1R43HL162218-01 |
|
NHLBI |
2022 |
|
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial |
1R61HL155858-01A1 |
|
NHLBI |
2022 |
|
Home sleep apnea testing compared to in-lab polysomnography for the evaluation of obstructive sleep apnea in children |
1R61HL162839-01 |
|
NHLBI |
2022 |
|
Treatment of Obstructive Sleep Apnea with Personalized Surgery in Children with Down Syndrome (TOPS-DS) |
1R61HL165345-01 |
|
NHLBI |
2022 |
|
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea |
1R61HL165366-01 |
|
NHLBI |
2022 |
|
The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation. |
1U01HL163242-01 |
|
NHLBI |
2022 |
|
2/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial) –DCC |
1U24HL155811-01A1 |
|
NHLBI |
2022 |
|
1/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial) |
1UG3HL155798-01A1 |
|
NHLBI |
2022 |
|
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes |
2R01HL102321-10A1 |
|
NHLBI |
2022 |